| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants.
|
Science
|
2002
|
12.75
|
|
2
|
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.
|
Lancet
|
2008
|
12.59
|
|
3
|
Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia.
|
N Engl J Med
|
2004
|
7.73
|
|
4
|
Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.
|
Blood
|
2005
|
5.82
|
|
5
|
Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors.
|
Blood
|
2003
|
3.88
|
|
6
|
Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
|
J Clin Oncol
|
2003
|
3.24
|
|
7
|
Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype.
|
Haematologica
|
2005
|
3.11
|
|
8
|
Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis.
|
Ann Neurol
|
2007
|
2.64
|
|
9
|
The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group.
|
Mult Scler
|
2010
|
2.45
|
|
10
|
A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation.
|
Blood
|
2008
|
1.94
|
|
11
|
Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus?
|
Blood
|
2011
|
1.78
|
|
12
|
Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation.
|
Haematologica
|
2006
|
1.73
|
|
13
|
Helical tomotherapy targeting total bone marrow after total body irradiation for patients with relapsed acute leukemia undergoing an allogeneic stem cell transplant.
|
Radiother Oncol
|
2011
|
1.63
|
|
14
|
Human mesenchymal stem cells and cyclosporin a exert a synergistic suppressive effect on in vitro activation of alloantigen-specific cytotoxic lymphocytes.
|
Biol Blood Marrow Transplant
|
2005
|
1.58
|
|
15
|
Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells.
|
Proc Natl Acad Sci U S A
|
2011
|
1.58
|
|
16
|
Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patients.
|
Clin Cancer Res
|
2006
|
1.52
|
|
17
|
A novel Bim-BH3-derived Bcl-XL inhibitor: biochemical characterization, in vitro, in vivo and ex-vivo anti-leukemic activity.
|
Cell Cycle
|
2008
|
1.45
|
|
18
|
Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis.
|
Blood
|
2003
|
1.39
|
|
19
|
Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia.
|
Blood
|
2002
|
1.39
|
|
20
|
Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease.
|
Br J Haematol
|
2013
|
1.31
|
|
21
|
Human mesenchymal stem cells promote survival of T cells in a quiescent state.
|
Stem Cells
|
2007
|
1.31
|
|
22
|
Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance.
|
Biol Blood Marrow Transplant
|
2009
|
1.25
|
|
23
|
Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application.
|
Haematologica
|
2008
|
1.23
|
|
24
|
Unrelated cord blood transplantation: outcomes after single-unit intrabone injection compared with double-unit intravenous injection in patients with hematological malignancies.
|
Transplantation
|
2013
|
1.18
|
|
25
|
Human mesenchymal stem cells inhibit antibody production induced in vitro by allostimulation.
|
Nephrol Dial Transplant
|
2007
|
1.17
|
|
26
|
T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia.
|
Exp Hematol
|
2005
|
1.15
|
|
27
|
Diabetes impairs the vascular recruitment of normal stem cells by oxidant damage, reversed by increases in pAMPK, heme oxygenase-1, and adiponectin.
|
Stem Cells
|
2009
|
1.14
|
|
28
|
Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord blood.
|
J Immunol
|
2014
|
1.12
|
|
29
|
Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation.
|
Haematologica
|
2004
|
1.08
|
|
30
|
Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
|
Haematologica
|
2008
|
1.08
|
|
31
|
Identical outcome after autologous or allogeneic genoidentical hematopoietic stem-cell transplantation in first remission of acute myelocytic leukemia carrying inversion 16 or t(8;21): a retrospective study from the European Cooperative Group for Blood and Marrow Transplantation.
|
J Clin Oncol
|
2008
|
1.06
|
|
32
|
Intra-bone marrow injection of bone marrow and cord blood cells: an alternative way of transplantation associated with a higher seeding efficiency.
|
Exp Hematol
|
2004
|
1.02
|
|
33
|
Stem cells in inflammatory demyelinating disorders: a dual role for immunosuppression and neuroprotection.
|
Expert Opin Biol Ther
|
2006
|
1.01
|
|
34
|
Transplant-related mortality and long-term graft function are significantly influenced by cell dose in patients undergoing allogeneic marrow transplantation.
|
Blood
|
2002
|
1.01
|
|
35
|
Rituximab treatment for Epstein-Barr virus DNAemia after alternative-donor hematopoietic stem cell transplantation.
|
Biol Blood Marrow Transplant
|
2010
|
0.98
|
|
36
|
p38 MAPK and JNK antagonistically control senescence and cytoplasmic p16INK4A expression in doxorubicin-treated endothelial progenitor cells.
|
PLoS One
|
2010
|
0.98
|
|
37
|
Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European survey.
|
J Clin Oncol
|
2002
|
0.98
|
|
38
|
Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker.
|
Blood
|
2009
|
0.96
|
|
39
|
Hematopoietic stem cell transplantation for de novo erythroleukemia: a study of the European Group for Blood and Marrow Transplantation (EBMT).
|
Blood
|
2002
|
0.95
|
|
40
|
Induction and survival of binucleated Purkinje neurons by selective damage and aging.
|
J Neurosci
|
2007
|
0.94
|
|
41
|
Association of Human Development Index with rates and outcomes of hematopoietic stem cell transplantation for patients with acute leukemia.
|
Blood
|
2010
|
0.89
|
|
42
|
Estimating the whole bone-marrow asset in humans by a computational approach to integrated PET/CT imaging.
|
Eur J Nucl Med Mol Imaging
|
2012
|
0.89
|
|
43
|
Donor multipotent mesenchymal stromal cells may engraft in pediatric patients given either cord blood or bone marrow transplantation.
|
Exp Hematol
|
2006
|
0.88
|
|
44
|
Donor lymphocyte infusions for the treatment of minimal residual disease in acute leukemia.
|
Blood
|
2007
|
0.88
|
|
45
|
Mesenchymal stromal cells, from indifferent spectators to principal actors. Are we going to witness a revolution in the scenario of allograft and immune-mediated disorders?
|
Haematologica
|
2007
|
0.87
|
|
46
|
Clinical scale ex vivo expansion of cord blood-derived outgrowth endothelial progenitor cells is associated with high incidence of karyotype aberrations.
|
Exp Hematol
|
2007
|
0.87
|
|
47
|
Mesenchymal stem cells protective effect in adriamycin model of nephropathy.
|
Cell Transplant
|
2008
|
0.87
|
|
48
|
Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome with rich marrow.
|
Blood
|
2003
|
0.87
|
|
49
|
Antileukemia effects of xanthohumol in Bcr/Abl-transformed cells involve nuclear factor-kappaB and p53 modulation.
|
Mol Cancer Ther
|
2008
|
0.86
|
|
50
|
High frequency of endothelial colony forming cells marks a non-active myeloproliferative neoplasm with high risk of splanchnic vein thrombosis.
|
PLoS One
|
2010
|
0.85
|
|
51
|
Factors influencing outcome and incidence of long-term complications in children who underwent autologous stem cell transplantation for acute myeloid leukemia in first complete remission.
|
Blood
|
2002
|
0.85
|
|
52
|
Contact with the bone marrow microenvironment readdresses the fate of transplanted hematopoietic stem cells.
|
Exp Hematol
|
2010
|
0.85
|
|
53
|
Adoptive immunotherapy mediated by ex vivo expanded natural killer T cells against CD1d-expressing lymphoid neoplasms.
|
Haematologica
|
2009
|
0.83
|
|
54
|
Differential effects of the type of iron chelator on the absolute number of hematopoietic peripheral progenitors in patients with β-thalassemia major.
|
Haematologica
|
2012
|
0.82
|
|
55
|
Hematopoietic stem cell transplantation for de novo acute megakaryocytic leukemia in first complete remission: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT).
|
Blood
|
2004
|
0.82
|
|
56
|
Intrabone transplant of cord blood stem cells establishes a local engraftment store: a functional PET/FDG study.
|
J Biomed Biotechnol
|
2012
|
0.81
|
|
57
|
Mesenchymal stromal cells improve renal injury in anti-Thy 1 nephritis by modulating inflammatory cytokines and scatter factors.
|
Clin Sci (Lond)
|
2011
|
0.80
|
|
58
|
Bone marrow or peripheral blood as a source of stem cells for allogeneic transplantation.
|
Haematologica
|
2002
|
0.80
|
|
59
|
Dose-effect relationship for cataract induction after single-dose total body irradiation and bone marrow transplantation for acute leukemia.
|
Int J Radiat Oncol Biol Phys
|
2002
|
0.80
|
|
60
|
Design and application of a novel PNA probe for the detection at single cell level of JAK2V617F mutation in Myeloproliferative Neoplasms.
|
BMC Cancer
|
2013
|
0.80
|
|
61
|
CMV infection after transplant from cord blood compared to other alternative donors: the importance of donor-negative CMV serostatus.
|
Biol Blood Marrow Transplant
|
2011
|
0.80
|
|
62
|
Freshly dissociated fetal neural stem/progenitor cells do not turn into blood.
|
Mol Cell Neurosci
|
2003
|
0.79
|
|
63
|
Anti-T-cell globulin: an essential ingredient for haematopoietic cell transplantation?
|
Lancet Oncol
|
2009
|
0.79
|
|
64
|
Mesenchymal stromal cells reset the scatter factor system and cytokine network in experimental kidney transplantation.
|
BMC Immunol
|
2014
|
0.78
|
|
65
|
Nonhuman primate allogeneic hematopoietic stem cell transplantation by intraosseus vs intravenous injection: Engraftment, donor cell distribution, and mechanistic basis.
|
Exp Hematol
|
2008
|
0.78
|
|
66
|
Imatinib: can one outwit chronic myeloid leukemia?
|
Haematologica
|
2002
|
0.78
|
|
67
|
[Mesenchymal stromal cells injection reduces acute rejection damage in a rat experimental model of kidney transplantation].
|
G Ital Nefrol
|
2011
|
0.76
|
|
68
|
Adult advanced chronic lymphocytic leukemia: computational analysis of whole-body CT documents a bone structure alteration.
|
Radiology
|
2014
|
0.76
|
|
69
|
Aberrant activation of ROS1 represents a new molecular defect in chronic myelomonocytic leukemia.
|
Leuk Res
|
2013
|
0.76
|
|
70
|
Stem cells for multiple sclerosis: promises and reality.
|
Regen Med
|
2007
|
0.75
|
|
71
|
Emerging targets for hematological malignancies.
|
Curr Opin Drug Discov Devel
|
2010
|
0.75
|
|
72
|
Comparison of BAVC to BuCy regimens in autologous stem cell transplantation for adult patients with acute myeloid leukemia.
|
Haematologica
|
2004
|
0.75
|